ONCY insider transaction filings

ONCOLYTICS BIOTECH INC — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-03. Screen ONCY transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-034McAdory John Bearden — Chief Operating OfficerGrant/award (A): 145,000 (derivative) @ $0EDGAR
2026-06-034Glover Stephen C. — DirectorGrant/award (A): 96,000 (derivative) @ $0EDGAR
2026-06-034Brown Deborah Margaret — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034RIGBY JONATHAN — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034Pisano Wayne — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034Holtham Angela — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034Look Kirk — Chief Financial OfficerGrant/award (A): 260,000 (derivative) @ $0EDGAR
2026-06-034Parsons James T. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034Aromando Andrew — Chief Business OfficerGrant/award (A): 260,000 (derivative) @ $0EDGAR
2026-06-034Kelly Jared — Chief Executive Officer, DirectorGrant/award (A): 755,000 (derivative) @ $0EDGAR
2026-06-034Andrews Patricia S — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034Seizinger Bernd R. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-034Hagerman Allison — Chief Technology OfficerGrant/award (A): 260,000 (derivative) @ $0EDGAR
2026-06-034Heineman Thomas Charles — Chief Medical OfficerGrant/award (A): 260,000 (derivative) @ $0EDGAR
2026-03-134Parsons James T. — DirectorPurchase (P): 10,000 @ $1.03EDGAR
2026-03-134Kelly Jared — Chief Executive Officer, DirectorPurchase (P): 5,050 @ $0.96EDGAR
2026-02-134Seizinger Bernd R. — DirectorPurchase (P): 60,000 @ $0.83 · Purchase (P): 40,000 @ $0.85EDGAR
2026-02-134Pisano Wayne — DirectorPurchase (P): 30,000 @ $0.84EDGAR
2026-02-134Look Kirk — Chief Financial OfficerPurchase (P): 12,000 @ $0.84EDGAR
2026-02-134Kelly Jared — Chief Executive Officer, DirectorPurchase (P): 5,600 @ $0.84 · Purchase (P): 29,500 @ $0.84EDGAR
2026-02-134Heineman Thomas Charles — Chief Medical OfficerPurchase (P): 12,132 @ $0.83EDGAR
2026-02-134Hagerman Allison — VP, Product DevelopmentPurchase (P): 10,000 @ $0.83EDGAR
2026-02-134Brown Deborah Margaret — DirectorPurchase (P): 25,000 @ $0.85EDGAR
2026-02-134Aromando Andrew — Chief Business OfficerPurchase (P): 29,600 @ $0.86EDGAR
2026-02-134Andrews Patricia S — DirectorPurchase (P): 35,400 @ $0.86EDGAR
2026-01-204Seizinger Bernd R. — DirectorPurchase (P): 100,000 @ $1.04EDGAR

Recent 8-K events — ONCOLYTICS BIOTECH INC

FiledFormItems reportedSource
2026-08-188-K8.01 — Other EventsEDGAR
2026-07-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-07-208-K8.01 — Other EventsEDGAR
2026-07-138-K8.01 — Other EventsEDGAR
2026-07-088-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K8.01 — Other EventsEDGAR
2026-06-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2026-06-018-K8.01 — Other EventsEDGAR
2026-05-228-K8.01 — Other EventsEDGAR
2026-05-048-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ONCY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →